PF-05175157 is a potent, selective small molecule inhibitor of protein kinase CK2, currently under investigation for its therapeutic potential in treating various solid tumors and hematologic malignancies… Read more
PF-05175157 is a potent, selective small molecule inhibitor of protein kinase CK2, currently under investigation for its therapeutic potential in treating various solid tumors and hematologic malignancies characterized by CK2 overexpression. This category provides access to high-quality reference standards and stable isotope labelled compounds essential for rigorous pharmaceutical research and development. Analytical chemists utilize these materials for impurity profiling, method validation, and precise quantitative analysis during drug development processes. The inclusion of the deuterated analog, PF-05175157-d6, allows laboratories to employ internal standards in mass spectrometry assays, facilitating accurate measurement of drug concentrations in complex biological matrices throughout pharmacokinetic studies. By integrating these reliable reference materials, research teams can maintain consistency and accuracy in their quality control protocols and analytical investigations related to this kinase inhibitor.